Claudia Fabiani Selected Research

Certolizumab Pegol

7/2019	Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.
11/2017	Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Fabiani Research Topics

Disease

34	Uveitis 05/2024 - 01/2010
7	Inflammation (Inflammations) 12/2021 - 01/2013
6	Scleritis (Episcleritis) 08/2022 - 10/2017
6	Macular Edema 03/2021 - 01/2010
5	Retinal Vasculitis 05/2024 - 01/2017
5	Anterior Uveitis 08/2023 - 11/2016
4	Fever (Fevers) 11/2023 - 01/2021
4	Panuveitis 08/2023 - 01/2019
4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2019 - 01/2010
4	Vasculitis (Vasculitides) 01/2018 - 01/2017
3	Axial Spondyloarthritis 01/2023 - 07/2018
3	Necrosis 07/2020 - 03/2019
3	Behcet Syndrome (Behcet's Syndrome) 01/2020 - 01/2017
2	Pneumonia (Pneumonitis) 11/2023 - 01/2020
2	Arthritis (Polyarthritis) 11/2023 - 01/2022
2	Vision Disorders (Hemeralopia) 11/2023 - 11/2016
2	Cryopyrin-Associated Periodic Syndromes 10/2023 - 10/2017
2	Blau syndrome 10/2023 - 10/2017
2	Posterior Uveitis 08/2023 - 02/2019
2	Intermediate Uveitis (Chronic Cyclitis) 08/2023 - 02/2019
2	Myositis (Idiopathic Inflammatory Myopathies) 07/2023 - 03/2022
2	VEXAS syndrome 01/2023 - 01/2022
2	Giant Cell Arteritis (Horton Disease) 01/2023 - 01/2022
2	Adult-Onset Still's Disease 12/2022 - 01/2019
2	Ankylosing Spondylitis 07/2018 - 11/2016
1	Blindness (Hysterical Blindness) 03/2024
1	Drug-Related Side Effects and Adverse Reactions 01/2024
1	Hypoalbuminemia 11/2023
1	Lymphadenopathy 11/2023
1	Hepatomegaly 11/2023
1	Ischemia 11/2023
1	Muscular Diseases (Myopathy) 11/2023
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2023
1	Neovascular Glaucoma 11/2023
1	Liver Failure 11/2023
1	autosomal dominant familial Periodic fever 10/2023
1	Familial Mediterranean Fever (Periodic Disease) 10/2023
1	Pars Planitis 08/2023
1	Inclusion Body Myositis 07/2023
1	Psoriatic Arthritis 05/2023
1	Sarcoidosis (Schaumann Disease) 01/2023
1	Myalgia 01/2023
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2023
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Serositis 01/2022
1	Pericarditis 01/2022
1	Murine Acquired Immunodeficiency Syndrome (MAIDS) 01/2022

Drug/Important Bio-Agent (IBA)

13	Adalimumab (Humira)FDA Link 08/2023 - 01/2017
12	SteroidsIBA 01/2023 - 01/2013
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 11/2016
10	InterleukinsIBA 01/2022 - 01/2017
7	Antirheumatic Agents (DMARD)IBA 11/2023 - 01/2017
7	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 01/2017
6	Fluorescein (Funduscein)FDA LinkGeneric 03/2024 - 01/2017
6	GlucocorticoidsIBA 01/2024 - 11/2020
6	Interleukin-1 (Interleukin 1)IBA 01/2021 - 01/2017
5	Tumor Necrosis Factor InhibitorsIBA 01/2024 - 11/2016
5	Infliximab (Remicade)FDA Link 02/2019 - 06/2018
5	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2019 - 01/2017
4	Biosimilar PharmaceuticalsIBA 01/2024 - 01/2019
4	tocilizumab (atlizumab)FDA Link 01/2023 - 07/2017
3	HLA Antigens (Human Leukocyte Antigens)IBA 05/2024 - 01/2020
3	Bevacizumab (Avastin)FDA Link 11/2023 - 01/2013
3	Immunosuppressive Agents (Immunosuppressants)IBA 08/2023 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2022
3	canakinumab FDA Link 01/2020 - 01/2017
2	HLA-B51 AntigenIBA 05/2024 - 01/2020
2	Retinaldehyde (Retinal)IBA 11/2023 - 01/2010
2	Complement System Proteins (Complement)IBA 11/2023 - 01/2018
2	Ferritins (Ferritin)IBA 11/2023 - 11/2023
2	AntibodiesIBA 07/2023 - 07/2020
2	EnzymesIBA 01/2023 - 01/2022
2	Colchicine FDA LinkGeneric 01/2023 - 01/2022
2	C-Reactive ProteinIBA 01/2022 - 07/2018
2	secukinumabIBA 01/2020 - 07/2018
2	Certolizumab Pegol FDA Link 07/2019 - 11/2017
2	golimumab FDA Link 07/2019 - 01/2019
2	Monoclonal AntibodiesIBA 03/2019 - 07/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2017 - 01/2017
1	HLA-B Antigens (HLA-B)IBA 05/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 11/2023
1	Calcineurin InhibitorsIBA 11/2023
1	Adenosine (Adenocard)FDA LinkGeneric 10/2023
1	5'-Nucleotidase (5' Nucleotidase)IBA 07/2023
1	Immunoglobulin G (IgG)IBA 07/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	Saline SolutionIBA 01/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 03/2022
1	Interleukin-6 InhibitorsIBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2020
1	Abatacept (Orencia)FDA Link 01/2020

Therapy/Procedure

11	Therapeutics 08/2023 - 01/2013
7	Biological Therapy 01/2023 - 01/2018
2	Duration of Therapy 01/2019 - 06/2018
1	Light Coagulation 11/2023
1	Intravitreal Injections 11/2023
1	Intradermal Injections 01/2023
1	Precision Medicine 12/2021